Rani Therapeutics Holdings (RANI) Live Share Price, Invest From India

Rani Therapeutics Holdings Stock Performance

as on November 5, 2026 at 7:59 am IST

Day's Low
Day's High
$0.57
Day's Price Range
$0.58
$0.57
0.45%
Downside
1.29%
Upside
52 Week's Low
52 Week's High
$0.55
52-Week Price Range
$2.63
$0.57
3.84%
Downside
359.31%
Upside

Rani Therapeutics Holdings share price movements today

Previous Close: $0.56
Open: $0.57
Volume: 611.1K
Market Cap: $82.9M
Day's Low - High: $0.57 - $0.58
52 Week Low - High: $0.55 - $2.63

Rani Therapeutics Holdings Historical Returns

1 Month Return: -31.94 %
3 Month Return: -31.14 %
1 Year Return: -74.33 %
3 Year Return: -71.85 %
5 Year Return: -98.03 %

Rani Therapeutics Holdings Stock Fundamentals & Key Indicators

Check Rani Therapeutics Holdings market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$82.9M

EPS (TTM)

-0.2691

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.19

Industry PE ratio

-3.13

PEG Ratio

-0.01

EBITDA

-31.9M

Revenue (TTM)

4.9M

Profit Margin

96.70%

Return On Equity TTM

-129.93%

Rani Therapeutics Holdings vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Rani Therapeutics Holdings with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Rani Therapeutics Holdings	Buy	$82.9M	-98.03%	-2.19	96.70%	0.00%
Moderna	Neutral	$88.5B	-36.16%	-27.78	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$141.7B	192.56%	32.27	86.04%	0.00%
Regeneron	Buy	$95.5B	47.41%	19.76	85.77%	0.40%

Stock Returns calculator for Rani Therapeutics Holdings Stock including INR - Dollar returns

The Rani Therapeutics Holdings stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Rani Therapeutics Holdings investment value today

Current value as on today

₹28,406

Returns

-₹71,594

(-71.59%)

Returns from Rani Therapeutics Holdings Stock

-₹73,367 (-73.37%)

Dollar Impact

₹1,773 (+1.77%)

Analyst Recommendation on Rani Therapeutics Holdings Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Rani Therapeutics Holdings. Average target price of $7.2

Rani Therapeutics Holdings Share Price Target

Get share price movements and forecasts by analysts on Rani Therapeutics Holdings.

What analysts predicted

92.05%UPSIDE

Target Price

$7.2

Current Price

$0.5726

Analyzed by

2 Analysts

High

Target

$7.20

Low

Rani Therapeutics Holdings target price $7.2, a slight upside of 92.05% compared to current price of $0.5726. According to 2 analysts rating.

Indian Investors' Interest in Rani Therapeutics Holdings Stock

Search interest for Rani Therapeutics Holdings Stock has decreased by -32% in the last 30 days, reflecting a downward trend in search activity.

Time period: October 6, 2026 to November 5, 2026

Change:-32% versus previous 30 day period

Rani Therapeutics Holdings Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	0	-	-	1	1	1
Gross Profit	-	0	0	0	0	-	-	1	1	1
Operating Income	-13	-14	-12	-11	-12	-10	-7	-8	-8	-8
EBITDA	-12	-13	-11	-11	-11	-10	-6	-8	-7	-8
Interest Expense	1	1	1	1	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-14	-14	-13	-12	-12	-11	-7	-9	-8	-8
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-7	-7	-6	-6	-7	-6	-5	-10	-7	-7
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	100.00%	0.00%	0.00%	100.00%	90.57%	100.00%

Rani Therapeutics Holdings Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Mar 2025	Dec 2025
Total Revenue	0	0	2	-	-	1	1
Gross Profit	0	0	2	-	0	1	0
Operating Income	-27	-16	-51	-63	-66	-53	-38
EBITDA	-26	-15	-52	-61	-61	-50	-37
Interest Expense	0	0	0	1	5	5	2
Depreciation	0	0	0	0	0	1	0
Income Before Tax	-26	-16	-53	-63	-67	-30	-40
Income Tax Expense	-	0	0	0	-	26	-
Net Income	-26	-16	-8	-30	-33	-30	-29
Net Profit Margin	100.00%	100.00%	100.00%	0.00%	0.00%	100.00%	44.89%

Rani Therapeutics Holdings Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-14	-14	-6	-12	-12	-11	-7	-9	-8	-8
Operating Cash Flow	-12	-9	-9	-8	-8	-5	-5	0	-6	-9
Investing Cash Flow	13	10	6	0	18	5	-	-30	-2	-14
Financing Cash Flow	0	0	0	7	-3	0	-1	44	0	18
Change in Cash	0	1	-2	0	6	0	-6	14	-8	-4

Rani Therapeutics Holdings Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Mar 2025	Dec 2025
Net Income	-26	-16	-8	-63	-33	-56	-29
Operating Cash Flow	-26	-14	-32	-46	-51	-35	-18
Investing Cash Flow	-1	-1	0	-72	29	19	-7
Financing Cash Flow	0	72	77	29	0	13	40
Change in Cash	-26	56	44	-89	-21	-2	14

Global Institutional Holdings in Rani Therapeutics Holdings

Check out the Institutions with significant holdings in Rani Therapeutics Holdings.

Funds	Holdings
MIR A IMRAN	21.53%
Peter Kolchinsky	7.36%
Vanguard	3.91%
VANGUARD INDEX FUNDS	3.88%
Fidelity Concord Street Trust	0.58%

See all

Insights on Rani Therapeutics Holdings

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 194.6% return, outperforming this stock by 266.2%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 869.6% return, outperforming this stock by 947.4%
NEGATIVE IMPACT
Price Dip
In the last 1 year, RANI stock has moved down by -77.8%

About Rani Therapeutics Holdings

Rani Therapeutics Holdings, Inc. functions as a clinical-stage biopharmaceutical enterprise focused on revolutionizing the delivery of biologic therapies through oral administration. Its flagship innovation, the RaniPill capsule, aims to supplant conventional subcutaneous or intravenous injections of biologics with a more convenient oral dosing method. The company maintains a comprehensive portfolio of investigational treatments. Among these is RT-101, an octreotide, which has progressed beyond Phase I clinical trials for the management of neuroendocrine tumors and acromegaly. Another promising candidate is RT-105, an anti-TNF-alpha antibody designed to address psoriatic arthritis. Additionally, RT-102, a parathyroid hormone for osteoporosis, is currently advancing through preclinical studies. Other therapies under development include RT-109, a human growth hormone for treating growth hormone deficiency; RT-110, a parathyroid hormone aimed at hypoparathyroidism; and RT-106, a basal insulin formulated for type 2 diabetes. Established in 2012, the company's corporate base is located in San Jose, California.

Organisation	Rani Therapeutics Holdings
Headquarters	2051 Ringwood Avenue, San Jose, CA, 95131, US
Industry	Biotechnology
CEO	Talat Imran

Key Management of Rani Therapeutics Holdings

Name	Title
Mr. Mir A. Imran	Executive Chairman
Ms. Kate McKinley M.B.A.	Chief Business Officer
Mr. Alireza Javadi Ph.D.	Chief Technical Officer
Dr. Mir Hashim	Chief Scientific Officer
Ms. Bella Vazquez	Senior Vice President of People & Administrative Services
Ms. Arvinder Dhalla	Vice President of Clinical Development
Mr. Talat Imran	CEO & Director
Mr. Nicholas Maestas	Chief Financial Officer
Mr. Jesper Hoeiland M.Sc.	Head of Strategy

FAQs

What is Rani Therapeutics Holdings share price today?

Rani Therapeutics Holdings share price today is $0.57 as on November 5, 2026 at 2:29 am IST at the close of the market. Rani Therapeutics Holdings share today touched a day high of $0.58 and a low of $0.57.

What is the 52 week high and 52 week low for Rani Therapeutics Holdings share?

Rani Therapeutics Holdings share touched a 52 week high of $2.63 on November 6, 2025 and a 52 week low of $0.55 on November 2, 2026. Rani Therapeutics Holdings stock price today i.e. November 5, 2026 at 2:29 am IST is closed at $0.57,which is 78.23% down from its 52 week high and 4.00% up from its 52 week low.

What is Rani Therapeutics Holdings's market capitalisation today?

Rani Therapeutics Holdings market capitalisation is $0.00T as on November 5, 2026 at 2:29 am IST.

How to invest in Rani Therapeutics Holdings Stock (RANI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Rani Therapeutics Holdings on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Rani Therapeutics Holdings Stock (RANI) from India?

Indian investors can start investing in Rani Therapeutics Holdings (RANI) shares with as little as ₹94.63999938964844 or $1 (as of November 5, 2026 at 8:26 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹946.40 in Rani Therapeutics Holdings stock (as per the Rupee-Dollar exchange rate as on November 5, 2026 at 8:26 am IST). Based on Rani Therapeutics Holdings share’s latest price of $0.57 as on November 5, 2026 at 2:29 am IST, you will get 17.4642 shares of Rani Therapeutics Holdings. Learn more about fractional shares .

What are the returns that Rani Therapeutics Holdings has given to Indian investors in the last 5 years?

Rani Therapeutics Holdings stock has given -98.03% share price returns and 27.31% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?